Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2 Recalled by LivaNova USA Inc Due to This recall is being initiated due to reports...

Date: November 16, 2018
Company: LivaNova USA Inc
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact LivaNova USA Inc directly.

Affected Products

VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2, RxOnly

Quantity: 643 units

Why Was This Recalled?

This recall is being initiated due to reports that that the therapy programming tablet with software version 1.5 errantly performs a normal mode diagnostic test instead of the selected system diagnostic test on Model 102 and Model 102R devices, if the output current is greater than 0.5mA. This can result in false high impedance values during patient follow-up.

Where Was This Sold?

This product was distributed to 47 states: AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NE, NV, NJ, NM, NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, WI, WY, DC

Affected (47 states)Not affected

About LivaNova USA Inc

LivaNova USA Inc has 10 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report